Sentences with phrase «cancer vaccine technology»

Today his company is developing a new cancer vaccine technology that teaches immune cells how to recognize and remove tumor cells.

Not exact matches

This technology could help researchers rapidly generate new peptide drugs to test on a variety of diseases, and it also raises the possibility of easily producing customized cancer vaccines for individual patients.

The 4 - year - old institute consists of six core research areas focused on a wide range of technologies, from cancer vaccines to robotic bees that will pollinate plants.

«This is an important demonstration of the possibilities opened up for immunotherapy by DMAb technology to direct in vivo production of antibodies of major relevance to human cancer,» said David B. Weiner, Ph.D., executive vice president of The Wistar Institute, director of The Wistar Institute Vaccine & Immunotherapy Center, W.W. Smith Charitable Trust Professor in Cancer Research, and senior author of the cancer,» said David B. Weiner, Ph.D., executive vice president of The Wistar Institute, director of The Wistar Institute Vaccine & Immunotherapy Center, W.W. Smith Charitable Trust Professor in Cancer Research, and senior author of the Cancer Research, and senior author of the study.

Cancer Vaccine Collaborative researchers Danila Valmori, Maha Ayyoub, Immanuel Luescher, and colleagues develop the first tetramer technology to monitor CD4 T cell responses to cancer vaccinCancer Vaccine Collaborative researchers Danila Valmori, Maha Ayyoub, Immanuel Luescher, and colleagues develop the first tetramer technology to monitor CD4 T cell responses to cancer vaccincancer vaccination.

Those selected for funding range from an antibacterial coating for orthopedic implants to a novel nano - vaccine technology to a potential next - generation cancer therapeutic.

Important reports from the Weiner lab include the first DNA vaccine studied for HIV as well as for cancer immune therapy of cutaneous T cell lymphoma, the early development of DNA encoded genetic adjuvants, including IL - 12, advances in gene optimization, and advances in electroporation technologies resulting in improved gene delivery.

An international team led by researchers at the Broad Institute of MIT and Harvard, the Harvard T.H. Chan School of Public Health and Fred Hutchinson Cancer Research Center uncovered the influence of genetic variation on vaccine effectiveness after applying cutting - edge DNA sequencing technology to almost 5,000 patient blood samples.

Wistar discoveries have led to the development of vaccines for rabies, rubella, and rotavirus, the identification of genes associated with different types of cancer, the development of monoclonal antibodies, and other significant research technologies and tools.

Grant Title: 01787: Clinical advancement of RNA - transfected CD40 - B cell vaccine technology for cancer therapy